(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...
(March 2021) The globe Essential Oils Market Research report examines the Key opportunities in the market and the influencing factors that are valuable for...